LUNGevity's 'No One Missed' campaign wants to raise lung cancer biomarker awareness, especially with traditionally underserved groups.
Lung cancer biomarker campaign, launched with AstraZeneca, boosts its reach and adds pharma supporters
The groups are called the MET Crusaders, the EGFR Resistors, the KRAS Kickers and the ROS1ders — and members are non-small cell lung cancer patients who …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
